Legend BiotechCorp Valuation
| LEGN Stock | USD 67.17 0.14 0.21% |
As of 2nd of October 2023, Free Cash Flow is likely to drop to about (237 M). In addition to that, Enterprise Value is likely to drop to about 7 B. Legend BiotechCorp secures a last-minute Real Value of $75.85 per share. The latest price of the firm is $67.17. At this time, the firm appears to be undervalued. Our model forecasts the value of Legend BiotechCorp from analyzing the firm fundamentals such as Operating Margin of (3.05) %, return on equity of -0.54, and Shares Outstanding of 182.29 M as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Beta (0.005) | Enterprise Value 11.4 B | Current Deferred Revenue 451 K | Net Debt -501.5 M | Accounts Payable 32.9 M |
Legend BiotechCorp Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Legend BiotechCorp's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
Please note that Legend BiotechCorp's price fluctuation is very steady at this time. Calculation of the real value of Legend BiotechCorp is based on 3 months time horizon. Increasing Legend BiotechCorp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Legend BiotechCorp is useful when determining the fair value of the Legend stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Legend BiotechCorp. Since Legend BiotechCorp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Legend Stock. However, Legend BiotechCorp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Estimating the potential upside or downside of Legend BiotechCorp helps investors to forecast how Legend stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Legend BiotechCorp more accurately as focusing exclusively on Legend BiotechCorp's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Legend BiotechCorp's intrinsic value based on its ongoing forecasts of Legend BiotechCorp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Legend BiotechCorp's closest peers. When choosing an evaluation method for Legend BiotechCorp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Legend BiotechCorp Investments |
|
Legend Valuation Drivers Correlation
Many accounts on the financial statements of Legend BiotechCorp are highly interrelated and sometimes correlated. Consequently, when conducting Legend's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Legend
Click cells to compare fundamentals
Legend Valuation Trend
Knowing Legend BiotechCorp's actual value is paramount for traders to make sound investment determinations. Legend BiotechCorp's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Legend BiotechCorp's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Legend BiotechCorp's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Legend Market Cap
Legend BiotechCorp is rated second overall in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 45.77 Billion. Legend BiotechCorp totals roughly 13.05 Billion in market capitalization claiming about 29% of equities under Health Care industry.Legend BiotechCorp Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Legend BiotechCorp's current stock value. Our valuation model uses many indicators to compare Legend BiotechCorp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Legend BiotechCorp competition to find correlations between indicators driving Legend BiotechCorp's intrinsic value. More Info.Legend BiotechCorp is currently regarded as number one stock in price to sales category among related companies. It is currently regarded as number one stock in price to book category among related companies fabricating about 0.27 of Price to Book per Price to Sales. The ratio of Price to Sales to Price to Book for Legend BiotechCorp is roughly 3.70 . As of 2nd of October 2023, Price to Book Value is likely to drop to 9.96. Comparative valuation analysis is a catch-all model that can be used if you cannot value Legend BiotechCorp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Legend BiotechCorp's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend BiotechCorp's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Legend BiotechCorp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Legend BiotechCorp and how it compares across the competition.
About Legend BiotechCorp Valuation
The stock valuation mechanism determines the current worth of Legend BiotechCorp on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Legend BiotechCorp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Legend BiotechCorp based exclusively on its fundamental and basic technical indicators. By analyzing Legend BiotechCorp's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Legend BiotechCorp's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Legend BiotechCorp. We calculate exposure to Legend BiotechCorp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Legend BiotechCorp's related companies.| Last Reported | Projected for 2023 | ||
| Gross Profit | 51.6 M | 62.4 M | |
| Profit Margin | (3.81) | (4.12) |
Legend BiotechCorp Quarterly Enterprise Value |
|
8 Steps to conduct Legend BiotechCorp's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Legend BiotechCorp's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Legend BiotechCorp's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Legend BiotechCorp's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Legend BiotechCorp's revenue streams: Identify Legend BiotechCorp's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Legend BiotechCorp's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Legend BiotechCorp's growth potential: Evaluate Legend BiotechCorp's management, business model, and growth potential.
- Determine Legend BiotechCorp's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Legend BiotechCorp's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Legend BiotechCorp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Legend BiotechCorp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 159 M |
Legend BiotechCorp Current Valuation Indicators
Valuation refers to the process of determining the present value of Legend BiotechCorp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Legend we look at many different elements of the entity such as Legend's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Legend BiotechCorp's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Legend BiotechCorp's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Legend BiotechCorp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Legend BiotechCorp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Legend BiotechCorp's worth.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.16) | Revenue Per Share 0.986 | Quarterly Revenue Growth 5.126 | Return On Assets (0.21) | Return On Equity (0.54) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.